analytica InnovationArea: Start-ups in the Spotlight

23-26 March 2010, Munich, Germany.
Following its successful premiere in 2008, analytica, the leading trade fair for industrial analysis, laboratory technology and biotechnology, will continue its initiative for new companies again in 2010. International start-ups and research organizations in the biotechnology sector will present their business ideas and document the importance of the life sciences in a special area known as the InnovationArea. Lectures and panel discussions at the Biotech Forum, which is located in the immediate vicinity of the InnovationArea, will give visitors additional insights into the trends and innovative strength of this industry.

The fact that research and development are heavily influenced by the innovative strength of new, smaller companies is well-known in the life-sciences sector. Each year the biotech industry grows by several dozen new companies. The research results of these start-ups and research institutes give the industry direction and important impetus. "The InnovationArea expands the scope of the traditional exhibition sectors at analytica to include an important, fundamental branch of industry, i.e. research and development. It gives new companies and research institutes in this sector a perfect platform for presenting their innovations, products, services, research results and business ideas to a broad-based domestic and international audience. It also gives them an opportunity to make new contacts and cultivate existing ones - and at attractive rates," says Thomas Rehbein, Exhibition Director of analytica, explaining the concept of the special exhibition sector.

However, the InnovationArea is more than just a cluster of exhibits. Its close physical proximity to the Biotech Forum and the fact that the themes of both platforms are closely related is intended to promote dialog. On all four days of the fair, the presentation stage will feature discussions and presentations about future technologies and research trends in the life sciences. The most important topics include industrial biotechnology and personalized healthcare, and Finance Day on Friday will examine ways to financially support new research organizations and start-ups.

The InnovationArea was an immediate success when it celebrated its premiere in 2008. The compact platform featured new biotech and life-science companies as well as start-ups in the nano-chemistry, micro-reaction technology and bioinformatics sectors. The fact that it got off to such as successful start is also reflected by the ratings that the InnovationArea received. Eighty percent of all exhibitors gave the new attraction a rating of good to excellent - ratings that it received by an impressive 85 percent of all visitors.

The basic perquisites for participating in the InnovationArea as well as all relevant facts and figures and an application form are available online at www.analytica.de/link/en/innovationarea.

About analytica
analytica, which includes the Analytica Conference, is the leading European trade fair for analysis, laboratory technology, biotechnology/life sciences, diagnostics and data and process management. It is held in Munich, the leading trade-fair venue and business location in the world. Visitors include decision-makers and users from the chemical, medical and pharmaceutical sectors as well as industrial and government research organizations. Analytica is held every two years and has established itself as a central marketplace for marketable products and solutions as well as innovations. The 22nd analytica is being held at the New Munich Trade Fair Centre from March 23-26, 2010.

analytica is part of an international network of trade fairs: It includes the trade fairs analytica, analytica China (Shanghai, Sept. 15-17, 2010), analytica Anacon India (Fall 2011) and analytica Vietnam (April 7-9, 2011). Additional information about the fair(s) and the program of events is available on the Internet at www.analytica.de.

Messe München International (MMI)
Messe München International (MMI) is one of the world's leading trade-fair companies. It organises around 40 trade fairs for capital and consumer goods, and key high-tech industries. Each year over 30,000 exhibitors from more than 100 countries, and over two million visitors from more than 200 countries take part in the events in Munich. In addition, MMI organises trade fairs in Asia, Russia, the Middle East and South America. With six subsidiaries abroad - in Europe and in Asia - and with 64 foreign representatives serving 89 countries, MMI has a truly global network. Via its six subsidiaries - in Europe and in Asia - and 64 foreign representatives actively serving over 90 countries, MMI has a worldwide business network. Environmental protection and sustainability are key priorities in all MMI's operations, at home and abroad.

Further information: www.messe-muenchen.de.

Most Popular Now

Accelerating NHS Digital Maturity: Paper…

Digitised clinical noting at South Tees Hospitals NHS Foundation Trust is creating efficiencies for busy doctors and nurses. The trust’s CCIO Dr Andrew Adair, deputy CCIO Dr John Greenaway, and...

AI Tool Helps Predict Who will Benefit f…

A study led by UCLA investigators shows that artificial intelligence (AI) could play a key role in improving treatment outcomes for men with prostate cancer by helping physicians determine who...

New Study Shows Promise for Gamified mHe…

A new study published in Multiple Sclerosis and Related Disorders highlights the potential of More Stamina, a gamified mobile health (mHealth) app designed to help people with Multiple Sclerosis (MS)...

AI in Healthcare: How do We Get from Hyp…

The Highland Marketing advisory board met to consider the government's enthusiasm for AI. To date, healthcare has mostly experimented with decision support tools, and their impact on the NHS and...

Research Shows AI Technology Improves Pa…

Existing research indicates that the accuracy of a Parkinson's disease diagnosis hovers between 55% and 78% in the first five years of assessment. That's partly because Parkinson's sibling movement disorders...

New AI Tool Accelerates Disease Treatmen…

University of Virginia School of Medicine scientists have created a computational tool to accelerate the development of new disease treatments. The tool goes beyond current artificial intelligence (AI) approaches by...

DMEA sparks: The Future of Digital Healt…

8 - 10 April 2025, Berlin, Germany. Digitalization is considered one of the key strategies for addressing the shortage of skilled workers - but the digital health sector also needs qualified...

First Therapy Chatbot Trial Shows AI can…

Dartmouth researchers conducted the first clinical trial of a therapy chatbot powered by generative AI and found that the software resulted in significant improvements in participants' symptoms, according to results...

Who's to Blame When AI Makes a Medi…

Assistive artificial intelligence technologies hold significant promise for transforming health care by aiding physicians in diagnosing, managing, and treating patients. However, the current trend of assistive AI implementation could actually...

DeepSeek: The "Watson" to Doct…

DeepSeek is an artificial intelligence (AI) platform built on deep learning and natural language processing (NLP) technologies. Its core products include the DeepSeek-R1 and DeepSeek-V3 models. Leveraging an efficient Mixture...

Stepping Hill Hospital Announced as SPAR…

Stepping Hill Hospital, part of Stockport NHS Foundation Trust, has replaced its bedside units with state-of-the art devices running a full range of information, engagement, communications and productivity apps, to...

DMEA 2025: Digital Health Worldwide in B…

8 - 10 April 2025, Berlin, Germany. From the AI Act, to the potential of the European Health Data Space, to the power of patient data in Scandinavia - DMEA 2025...